Build Your Comparison

Side-by-side financial analysis
FLGC logo
FLGC
CGC logo
CGC
TLRY logo
TLRY
ACB logo
ACB
CRON logo
CRON
KO logo
KO
Try popular comparisons:

Stock Comparison

FLGC vs CGC vs TLRY vs ACB vs CRON vs KO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
FLGC
Flora Growth Corp.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$88M
5Y Perf.-99.8%
CGC
Canopy Growth Corporation

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$372M
5Y Perf.-99.6%
TLRY
Tilray Brands, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$551M
5Y Perf.-52.8%
ACB
Aurora Cannabis Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$181M
5Y Perf.-96.0%
CRON
Cronos Group Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • CA
Market Cap$1.01B
5Y Perf.-70.4%
KO
The Coca-Cola Company

Beverages - Non-Alcoholic

Consumer DefensiveNYSE • US
Market Cap$341.71B
5Y Perf.+47.5%

FLGC vs CGC vs TLRY vs ACB vs CRON vs KO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
FLGC logoFLGC
CGC logoCGC
TLRY logoTLRY
ACB logoACB
CRON logoCRON
KO logoKO
IndustryDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericDrug Manufacturers - Specialty & GenericBeverages - Non-Alcoholic
Market Cap$88M$372M$551M$181M$1.01B$341.71B
Revenue (TTM)$14M$312M$1.17B$311M$206M$49.28B
Net Income (TTM)$-120M$-367M$-2.95B$-75M$-2M$13.70B
Gross Margin43.3%24.9%28.0%56.6%32.8%61.7%
Operating Margin-30.7%-33.0%-266.0%0.3%-0.1%29.3%
Forward P/E31.0x24.3x
Total Debt$54M$325M$451M$24M$2M$45.49B
Cash & Equiv.$6M$509M$304M$113M$792M$10.27B

FLGC vs CGC vs TLRY vs ACB vs CRON vs KOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

FLGC
CGC
TLRY
ACB
CRON
KO
StockMay 21Mar 26Return
Flora Growth Corp. (FLGC)1000.2-99.8%
Canopy Growth Corpo… (CGC)1000.4-99.6%
Tilray Brands, Inc. (TLRY)10047.2-52.8%
Aurora Cannabis Inc. (ACB)1004.0-96.0%
Cronos Group Inc. (CRON)10029.6-70.4%
The Coca-Cola Compa… (KO)100147.5+47.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: FLGC vs CGC vs TLRY vs ACB vs CRON vs KO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: KO leads in 4 of 7 categories (6-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Canopy Growth Corporation is the stronger pick specifically for growth and revenue expansion. TLRY and CRON also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇KO emerged as the overall leader. Track its performance:
FLGC
Flora Growth Corp.
The Healthcare Pick

Among these 6 stocks, FLGC doesn't own a clear edge in any measured category.

Best for: healthcare exposure
CGC
Canopy Growth Corporation
The Income Pick

CGC is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.

  • Dividend streak 0 yrs, beta 1.74
  • Rev growth 79.8%, EPS growth 84.1%, 3Y rev CAGR 13.2%
  • 79.8% revenue growth vs FLGC's -75.6%
Best for: income & stability and growth exposure
TLRY
Tilray Brands, Inc.
The Momentum Pick

TLRY ranks third and is worth considering specifically for momentum.

  • +11.3% vs FLGC's -74.3%
Best for: momentum
ACB
Aurora Cannabis Inc.
The Healthcare Pick

ACB doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.

Best for: healthcare exposure
CRON
Cronos Group Inc.
The Long-Run Compounder

CRON is the clearest fit if your priority is long-term compounding and sleep-well-at-night.

  • 15.4% 10Y total return vs KO's 115.0%
  • Lower volatility, beta 0.93, Low D/E 0.1%, current ratio 19.59x
  • Beta 0.93, current ratio 19.59x
  • Beta 0.93 vs FLGC's 3.12, lower leverage
Best for: long-term compounding and sleep-well-at-night
KO
The Coca-Cola Company
The Value Play

KO carries the broadest edge in this set and is the clearest fit for value and quality.

  • Lower P/E (24.3x vs 31.0x)
  • 27.8% margin vs FLGC's -8.3%
  • 2.6% yield; 56-year raise streak; the other 5 pay no meaningful dividend
  • 13.1% ROA vs FLGC's -192.1%, ROIC 15.8% vs -5.5%
Best for: value and quality
See the full category breakdown
CategoryWinnerWhy
GrowthCGC logoCGC79.8% revenue growth vs FLGC's -75.6%
ValueKO logoKOLower P/E (24.3x vs 31.0x)
Quality / MarginsKO logoKO27.8% margin vs FLGC's -8.3%
Stability / SafetyCRON logoCRONBeta 0.93 vs FLGC's 3.12, lower leverage
DividendsKO logoKO2.6% yield; 56-year raise streak; the other 5 pay no meaningful dividend
Momentum (1Y)TLRY logoTLRY+11.3% vs FLGC's -74.3%
Efficiency (ROA)KO logoKO13.1% ROA vs FLGC's -192.1%, ROIC 15.8% vs -5.5%

FLGC vs CGC vs TLRY vs ACB vs CRON vs KO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

FLGCFlora Growth Corp.
FY 2021
Pharmaceuticals and Nutraceuticals
100.0%$2M
CGCCanopy Growth Corporation
FY 2025
Other Revenue
0.0%$0
TLRYTilray Brands, Inc.
FY 2025
Cannabis Segment
36.1%$331M
Distribution Revenue
29.6%$271M
Beverage Alcohol Business
27.7%$253M
Wellness Business
6.6%$60M
ACBAurora Cannabis Inc.

Segment breakdown not available.

CRONCronos Group Inc.
FY 2025
Cannabis Flower
74.0%$108M
Cannabis Extracts
25.7%$38M
Product and Service, Other
0.3%$411,000
KOThe Coca-Cola Company
FY 2025
Pacific
84.6%$31.6B
Bottling investments
15.4%$5.7B

FLGC vs CGC vs TLRY vs ACB vs CRON vs KO — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLKOLAGGINGCRON

Income & Cash Flow (Last 12 Months)

KO leads this category, winning 4 of 6 comparable metrics.

KO is the larger business by revenue, generating $49.3B annually — 3399.1x FLGC's $14M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to FLGC's -8.3%. On growth, CRON holds the edge at +38.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…CRON logoCRONCronos Group Inc.KO logoKOThe Coca-Cola Com…
RevenueTrailing 12 months$14M$312M$1.2B$311M$206M$49.3B
EBITDAEarnings before interest/tax-$4M-$63M-$3.0B$14M$3M$15.5B
Net IncomeAfter-tax profit-$120M-$367M-$2.9B-$75M-$2M$13.7B
Free Cash FlowCash after capex-$9M-$77M-$94M-$36M$26M$12.6B
Gross MarginGross profit ÷ Revenue+43.3%+24.9%+28.0%+56.6%+32.8%+61.7%
Operating MarginEBIT ÷ Revenue-30.7%-33.0%-2.7%+0.3%-0.1%+29.3%
Net MarginNet income ÷ Revenue-8.3%-117.4%-2.5%-24.1%-1.0%+27.8%
FCF MarginFCF ÷ Revenue-63.5%-24.6%-8.1%-11.6%+12.9%+25.5%
Rev. Growth (YoY)Latest quarter vs prior year-2.6%+9.6%+3.0%-57.9%+38.2%+12.1%
EPS Growth (YoY)Latest quarter vs prior year+2.6%+72.0%+70.7%-125.0%+124.7%+18.2%
KO leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — TLRY and KO each lead in 2 of 5 comparable metrics.
MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…CRON logoCRONCronos Group Inc.KO logoKOThe Coca-Cola Com…
Market CapShares × price$88M$372M$551M$181M$1.0B$341.7B
Enterprise ValueMkt cap + debt − cash$87M$243M$698M$118M$222M$376.9B
Trailing P/EPrice ÷ TTM EPS-5.55x-1.55x-0.14x-1.92x-110.61x26.12x
Forward P/EPrice ÷ next-FY EPS est.30.97x24.27x
PEG RatioP/E ÷ EPS growth rate2.34x
EV / EBITDAEnterprise value multiple25.45x
Price / SalesMarket cap ÷ Revenue1.49x1.09x0.49x0.80x5.24x7.13x
Price / BookPrice ÷ Book value/share19.61x4.18x0.21x0.46x0.91x9.99x
Price / FCFMarket cap ÷ FCF6679.09x64.52x
Evenly matched — TLRY and KO each lead in 2 of 5 comparable metrics.

Profitability & Efficiency

KO leads this category, winning 6 of 9 comparable metrics.

KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-3 for FLGC. CRON carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to KO's 1.33x. On the Piotroski fundamental quality scale (0–9), CRON scores 7/9 vs FLGC's 3/9, reflecting strong financial health.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…CRON logoCRONCronos Group Inc.KO logoKOThe Coca-Cola Com…
ROE (TTM)Return on equity-3.3%-49.5%-136.5%-13.4%-0.2%+41.1%
ROA (TTM)Return on assets-192.1%-31.8%-100.6%-10.1%-0.2%+13.1%
ROICReturn on invested capital-5.5%-16.0%-66.2%-25.8%-0.7%+15.8%
ROCEReturn on capital employed-6.9%-15.0%-78.1%-25.6%-0.3%+17.3%
Piotroski ScoreFundamental quality 0–9354477
Debt / EquityFinancial leverage0.76x0.33x0.22x0.05x0.00x1.33x
Net DebtTotal debt minus cash$48M-$183M$147M-$89M-$790M$35.2B
Cash & Equiv.Liquid assets$6M$509M$304M$113M$792M$10.3B
Total DebtShort + long-term debt$54M$325M$451M$24M$2M$45.5B
Interest CoverageEBIT ÷ Interest expense-18.87x-5.99x-89.43x-1.30x10.70x
KO leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

TLRY leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in KO five years ago would be worth $16,528 today (with dividends reinvested), compared to $25 for FLGC. Over the past 12 months, TLRY leads with a +1134.0% total return vs FLGC's -74.3%. The 3-year compound annual growth rate (CAGR) favors TLRY at 45.0% vs FLGC's -62.9% — a key indicator of consistent wealth creation.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…CRON logoCRONCronos Group Inc.KO logoKOThe Coca-Cola Com…
YTD ReturnYear-to-date+5.3%-18.7%-51.3%-32.5%+0.4%+16.4%
1-Year ReturnPast 12 months-74.3%-25.0%+1134.0%-37.4%+41.9%+17.7%
3-Year ReturnCumulative with dividends-94.9%-84.0%+205.2%-47.7%+58.5%+39.3%
5-Year ReturnCumulative with dividends-99.8%-99.6%-72.0%-96.6%-67.5%+65.3%
10-Year ReturnCumulative with dividends-99.8%-95.4%-78.9%-93.4%+1542.4%+115.0%
CAGR (3Y)Annualised 3-year return-62.9%-45.7%+45.0%-19.4%+16.6%+11.7%
TLRY leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

KO leads this category, winning 2 of 2 comparable metrics.

KO is the less volatile stock with a -0.23 beta — it tends to amplify market swings less than FLGC's 3.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 94.5% from its 52-week high vs FLGC's 15.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…CRON logoCRONCronos Group Inc.KO logoKOThe Coca-Cola Com…
Beta (5Y)Sensitivity to S&P 5003.12x1.74x1.93x1.64x0.93x-0.23x
52-Week HighHighest price in past year$47.00$2.38$15.70$6.67$3.43$84.04
52-Week LowLowest price in past year$5.86$0.84$0.35$2.73$1.84$65.35
% of 52W HighCurrent price vs 52-week peak+15.3%+40.6%+30.1%+43.9%+79.0%+94.5%
RSI (14)Momentum oscillator 0–10047.133.233.831.847.149.2
Avg Volume (50D)Average daily shares traded11K10.1M4.9M1.1M1.6M13.6M
KO leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

KO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: CGC as "Hold", TLRY as "Hold", ACB as "Hold", CRON as "Hold", KO as "Buy". Consensus price targets imply 1396.1% upside for CGC (target: $14) vs -15.1% for CRON (target: $2). KO is the only dividend payer here at 2.56% yield — a key consideration for income-focused portfolios.

MetricFLGC logoFLGCFlora Growth Corp.CGC logoCGCCanopy Growth Cor…TLRY logoTLRYTilray Brands, In…ACB logoACBAurora Cannabis I…CRON logoCRONCronos Group Inc.KO logoKOThe Coca-Cola Com…
Analyst RatingConsensus buy/hold/sellHoldHoldHoldHoldBuy
Price TargetConsensus 12-month target$14.47$10.00$5.92$2.30$86.13
# AnalystsCovering analysts2620141548
Dividend YieldAnnual dividend ÷ price+2.6%
Dividend StreakConsecutive years of raises0056
Dividend / ShareAnnual DPS$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%0.0%+1.0%+0.2%
KO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

KO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TLRY leads in 1 (Total Returns). 1 tied.

Best OverallThe Coca-Cola Company (KO)Leads 4 of 6 categories
Loading custom metrics...

FLGC vs CGC vs TLRY vs ACB vs CRON vs KO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is FLGC or CGC or TLRY or ACB or CRON or KO a better buy right now?

For growth investors, Canopy Growth Corporation (CGC) is the stronger pick with 79.

8% revenue growth year-over-year, versus -75. 6% for Flora Growth Corp. (FLGC). The Coca-Cola Company (KO) offers the better valuation at 26. 1x trailing P/E (24. 3x forward), making it the more compelling value choice. Analysts rate The Coca-Cola Company (KO) a "Buy" — based on 48 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — FLGC or CGC or TLRY or ACB or CRON or KO?

On forward P/E, The Coca-Cola Company is actually cheaper at 24.

3x.

03

Which is the better long-term investment — FLGC or CGC or TLRY or ACB or CRON or KO?

Over the past 5 years, The Coca-Cola Company (KO) delivered a total return of +65.

3%, compared to -99. 8% for Flora Growth Corp. (FLGC). Over 10 years, the gap is even starker: CRON returned +1542% versus FLGC's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — FLGC or CGC or TLRY or ACB or CRON or KO?

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

23β versus Flora Growth Corp. 's 3. 12β — meaning FLGC is approximately -1435% more volatile than KO relative to the S&P 500. On balance sheet safety, Cronos Group Inc. (CRON) carries a lower debt/equity ratio of 0% versus 133% for The Coca-Cola Company — giving it more financial flexibility in a downturn.

05

Which is growing faster — FLGC or CGC or TLRY or ACB or CRON or KO?

By revenue growth (latest reported year), Canopy Growth Corporation (CGC) is pulling ahead at 79.

8% versus -75. 6% for Flora Growth Corp. (FLGC). On earnings-per-share growth, the picture is similar: Flora Growth Corp. grew EPS 100. 0% year-over-year, compared to -76. 4% for Aurora Cannabis Inc.. Over a 3-year CAGR, CRON leads at 30. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — FLGC or CGC or TLRY or ACB or CRON or KO?

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -266. 3% for Tilray Brands, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -277. 9% for TLRY. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is FLGC or CGC or TLRY or ACB or CRON or KO more undervalued right now?

On forward earnings alone, The Coca-Cola Company (KO) trades at 24.

3x forward P/E versus 31. 0x for Cronos Group Inc. — 6. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CGC: 1396. 1% to $14. 47.

08

Which pays a better dividend — FLGC or CGC or TLRY or ACB or CRON or KO?

In this comparison, KO (2.

6% yield) pays a dividend. FLGC, CGC, TLRY, ACB, CRON do not pay a meaningful dividend and should not be held primarily for income.

09

Is FLGC or CGC or TLRY or ACB or CRON or KO better for a retirement portfolio?

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

23), 2. 6% yield, +115. 0% 10Y return). Flora Growth Corp. (FLGC) carries a higher beta of 3. 12 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +115. 0%, FLGC: -99. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between FLGC and CGC and TLRY and ACB and CRON and KO?

These companies operate in different sectors (FLGC (Healthcare) and CGC (Healthcare) and TLRY (Healthcare) and ACB (Healthcare) and CRON (Healthcare) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: FLGC is a small-cap quality compounder stock; CGC is a small-cap high-growth stock; TLRY is a small-cap quality compounder stock; ACB is a small-cap quality compounder stock; CRON is a small-cap high-growth stock; KO is a large-cap quality compounder stock. KO pays a dividend while FLGC, CGC, TLRY, ACB, CRON do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.